Umb Bank, N.A. Dexcom Inc Transaction History

Umb Bank, N.A.

$6.22 Billion
Q4 2024

A detailed history of Umb Bank, N.A. transactions in Dexcom Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 1,678 shares of DXCM stock, worth $114,590. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,678

Previous 920 82.39%

Holding current value

$114,590

Previous $61,000 113.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	BUY	$65.68 - $81.01 $49,785 - $61,405	758 Added 82.39%	1,678 $130,000
Q3 2024 Oct 08, 2024	SELL	$64.0 - $116.06 $29,120 - $52,807	-455 Reduced 33.09%	920 $61,000
Q2 2024 Jul 29, 2024	SELL	$110.31 - $140.45 $26,805 - $34,129	-243 Reduced 15.02%	1,375 $155,000
Q1 2024 Apr 26, 2024	SELL	$114.22 - $140.1 $13,135 - $16,111	-115 Reduced 6.64%	1,618 $224,000
Q4 2023 Jan 23, 2024	SELL	$75.49 - $124.16 $80,245 - $131,982	-1,063 Reduced 38.02%	1,733 $215,000
Q3 2023 Oct 18, 2023	BUY	$86.06 - $137.93 $17,556 - $28,137	204 Added 7.87%	2,796 $260,000
Q2 2023 Jul 25, 2023	SELL	$112.47 - $130.98 $52,186 - $60,774	-464 Reduced 15.18%	2,592 $333,000
Q1 2023 Apr 11, 2023	SELL	$104.0 - $122.92 $23,296 - $27,534	-224 Reduced 6.83%	3,056 $355,000
Q4 2022 Jan 10, 2023	BUY	$84.98 - $122.67 $122,541 - $176,890	1,442 Added 78.45%	3,280 $371,000
Q3 2022 Oct 13, 2022	BUY	$76.35 - $94.18 $10,230 - $12,620	134 Added 7.86%	1,838 $148,000
Q2 2022 Jul 20, 2022	BUY	$67.99 - $132.89 $83,491 - $163,188	1,228 Added 257.98%	1,704 $127,000
Q1 2022 Apr 22, 2022	SELL	$94.08 - $130.2 $4,045 - $5,598	-43 Reduced 8.29%	476 $243,000
Q4 2021 Feb 09, 2022	BUY	$129.87 - $162.82 $67,402 - $84,503	519 New	519 $279,000

Others Institutions Holding DXCM

# of Institutions

1,085

Shares Held

352M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account